Assignee
MAXIM PHARM INC
US·25 granted patents·332 citations·filing 1993–2002
Top patents by PatentIndex Score
25 records- 0185US6270781B1Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitorsMAXIM PHARM INC·Filed 1999·Granted Aug 7, 2001·118 cites·9 claims
- 0283US6407133B2Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2001·Granted Jun 18, 2002·12 cites·7 claims
- 0381US6242473B1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 1999·Granted Jun 5, 2001·33 cites·12 claims
- 0480US6350785B2Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitorsMAXIM PHARM INC·Filed 2001·Granted Feb 26, 2002·25 cites·24 claims
- 0578US6893633B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted May 17, 2005·8 cites·15 claims
- 0677US6790440B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted Sep 14, 2004·7 cites·9 claims
- 0777US6305380B1Method for treatment of cancer and infectious diseaseMAXIM PHARM INC·Filed 2000·Granted Oct 23, 2001·8 cites·18 claims
- 0875US6531120B2Ophthalmic histamine compositions and uses thereofMAXIM PHARM INC·Filed 2001·Granted Mar 11, 2003·7 cites·12 claims
- 0974US6730692B2Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2002·Granted May 4, 2004·4 cites·13 claims
- 1074US6375946B1Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 2000·Granted Apr 23, 2002·4 cites·16 claims
- 1172US6462067B1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2000·Granted Oct 8, 2002·3 cites·18 claims
- 1271US6613788B1Elevation of circulating blood histamine levelsMAXIM PHARM INC·Filed 2000·Granted Sep 2, 2003·2 cites·22 claims
- 1370US6821510B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted Nov 23, 2004·3 cites·10 claims
- 1470US6245563B1Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 2000·Granted Jun 12, 2001·2 cites·5 claims
- 1570US6063373AEnhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 1997·Granted May 16, 2000·33 cites·5 claims
- 1662US6403806B1Synthesis of histamine dihydrochlorideMAXIM PHARM INC·Filed 1999·Granted Jun 11, 2002·8 cites·9 claims
- 1760US5728378APreparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activityMAXIM PHARM INC·Filed 1993·Granted Mar 17, 1998·23 cites·15 claims
- 1854US6071942AElevation of circulating blood histamine levelsMAXIM PHARM INC·Filed 1997·Granted Jun 6, 2000·9 cites·9 claims
- 1946US6528654B2Synthesis of histamine dihydrochlorideMAXIM PHARM INC·Filed 2001·Granted Mar 4, 2003·0 cites·8 claims
- 2046US5961969AStable circulating histamine levelsMAXIM PHARM INC·Filed 1996·Granted Oct 5, 1999·8 cites·37 claims
- 2143US6155266AMethod for treatment of cancer and infectious diseaseMAXIM PHARM INC·Filed 1999·Granted Dec 5, 2000·3 cites·9 claims
- 2241US6221893B1Administration of histamine for therapeutic purposesMAXIM PHARM INC·Filed 1996·Granted Apr 24, 2001·5 cites·23 claims
- 2341US6071509AEnhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 1996·Granted Jun 6, 2000·5 cites·16 claims
- 2434US5670311APeptides for detecting antibodies to HTLV-2MAXIM PHARM INC·Filed 1995·Granted Sep 23, 1997·1 cites·6 claims
- 2533US6003516AMethod for treatment of cancer and infectious diseaseMAXIM PHARM INC·Filed 1998·Granted Dec 21, 1999·1 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →